Granite Point Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,000,000	Closed	-$141M	–	214
2020 Q4	$141M	Buy	1,000,000 +260,000	+35%	+$33.3M	7.22%	6
2020 Q3	$82.5M	Sell	740,000 -1,610,000	-69%	-$180M	4.47%	7
2020 Q2	$263M	Buy	+2,350,000	New	+$231M	13.4%	2
2020 Q1	–	Sell	-250,000	Closed	-$23.8M	–	105
2019 Q4	$23.8M	Buy	250,000 +100,000	+67%	+$8.65M	3.71%	7
2019 Q3	$11.4M	Sell	150,000 -375,000	-71%	-$31.2M	1.79%	7
2019 Q2	$46M	Buy	525,000 +25,000	+5%	+$2.13M	3.1%	10
2019 Q1	$45.3M	Buy	+500,000	New	+$42.5M	4.38%	7
2018 Q4	–	Sell	-500,000	Closed	-$47.9M	–	126
2018 Q3	$47.9M	Buy	500,000 +115,000	+30%	+$11.1M	3.18%	10
2018 Q2	$36.6M	Buy	+385,000	New	+$35.4M	3.28%	9